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Abstract
Hepatic expression of iron homeostasis genes and serum iron parameters predict the suc-
cess of immunosuppression withdrawal following clinical liver transplantation, a phenome-
non known as spontaneous operational tolerance. In experimental animal models,
spontaneous liver allograft tolerance is established through a process that requires intra-
hepatic lymphocyte activation and deletion. Our aim was to determine if changes in sys-
temic iron status regulate intra-hepatic lymphocyte responses. We used a murine model of
lymphocyte-mediated acute liver inflammation induced by Concanavalin A (ConA) injection
employing mice fed with an iron-deficient (IrDef) or an iron-balanced diet (IrRepl). While the
mild iron deficiency induced by the IrDef diet did not significantly modify the steady state
immune cell repertoire and systemic cytokine levels, it significantly dampened inflammatory
liver damage after ConA challenge. These findings were associated with a marked
decrease in T cell and NKT cell activation following ConA injection in IrDef mice. The
decreased liver injury observed in IrDef mice was independent from changes in the gut
microflora, and was replicated employing an iron specific chelator that did not modify intra-
hepatic hepcidin secretion. Furthermore, low-dose iron chelation markedly impaired the
activation of isolated T cells in vitro. All together, these results suggest that small changes
in iron homeostasis can have a major effect in the regulation of intra-hepatic lymphocyte
mediated responses.
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Introduction
Iron homeostasis and the immune system are closely interconnected. Inflammatory cytokines
induce a rapid increase of hepcidin [1], the central mediator of iron homeostasis, which
reduces iron export from enterocytes, hepatocytes and, most importantly, macrophages [2].
This results in iron accumulation within macrophages and decreased circulating iron levels,
which appears to be an effective defence strategy against extracellular microorganisms that
need access to iron to exert pathogenic effects [2]. On the other hand, iron loaded macrophages
exhibit reduced effector functions, which can compromise their capacity to clear intra-cellular
infections [3, 4]. Iron also contributes to the formation of potent reactive radicals, which pro-
mote oxidative stress and induce inflammation and tissue injury. Thus, iron restriction has
been shown to ameliorate oxidative stress and inflammatory organ damage in models of
murine acute hepatitis [5, 6], experimental autoimmune encephalomyelitis (EAE) [7], renal
interstitial fibrosis [8] and type 2 diabetes in rats [9]. In addition to its effects on innate
immune responses and inflammation, iron is also required for the function and differentiation
of adaptive immune cells such as T lymphocytes. Thus, iron deficiency impairs T cell prolifera-
tion in vitro [10]. The impact of iron homeostasis manipulations on lymphocyte function in
vivo, however, has not been investigated in detail.
A role for iron homeostasis in the regulation of intra-hepatic lymphocyte responses and in
the development of transplantation tolerance has been recently suggested on the basis of the
results of a clinical trial in which immunosuppressive drugs were intentionally withdrawn
from a cohort of 98 long-term surviving liver transplant recipients [11]. As compared to toler-
ant liver recipients who successfully discontinued immunosuppression and age-matched
healthy individuals, non-tolerant patients who rejected during the weaning process exhibited
lower serum hepcidin and ferritin levels, as well as lower intra-hepatic iron content and hepci-
din gene expression. An intra-hepatic iron-related gene expression signature was indeed the
most accurate marker to predict the outcome of the drug withdrawal protocol. The phenome-
non of spontaneous liver allograft tolerance has been extensively studied in experimental ani-
mal models, particularly in rodents, in which an essential step in the induction of tolerance is
the activation and subsequent deletion of liver infiltrating lymphocytes [12, 13]. On account of
these data, we hypothesized that small changes in iron homeostasis could influence intra-
hepatic immune responses by interfering with intra-hepatic lymphocyte activation. To test this
hypothesis, in the current study we induced mild iron deficiency in mice by administering
either an iron-free diet or low-dose iron chelators, and assessed how iron deficiency influenced
intra-hepatic lymphocyte activation and its downstream effects. Reduction of iron availability
significantly interfered with lymphocyte activation, proliferation and cytokine production and
resulted in dampened immune-mediated hepatitis. These findings highlight a previously not
well-recognized phenomenon through which small changes in iron homeostasis can influence
outcomes in inflammatory liver disorders.
Material and Methods
Mice
Male C57Bl/6 mice (purchased from Charles River) were bred under specific pathogen-free
conditions. All procedures were conducted in accordance with national and institutional guide-
lines for animal care and use and have been approved by the Denmark Hill Animal Welfare
and Ethical Review Body (AWERB–KCL) and the Home Office. Anesthesia was performed by
isoflurane inhalation whereas euthanasia was performed in CO2 chamber.
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Four-week old mice were fed with either iron deficient (<6mg/kg iron) or iron replete (iron
deficient diet supplemented with 200 mg/kg iron carbonyl) diets (SAFE, France) for a total of 3
weeks prior to the performance of experiments. In some experiments, mice also received an
antibiotic cocktail consisting of ampicillin 1 g/L, vancomycin 0.5 g/L, (Laboratoiros Normon S.
A., Spain), metronidazole 1 g/L (BBraun Medical S.A., Spain) and neomycin 1 g/L (Laborator-
ios Salvat, Spain), which was added to drinking water and changed every 3 days for the entire
duration of the 3-week period as described [14].
Concanavalin A (ConA) induced hepatitis
In order to investigate a potential iron-related functional effect in immune system, we used
an immune-modulated model of acute hepatitis using a sublethal injection of Concanavalin
A (ConA) [15]. Immune-mediated acute hepatitis was induced by intravenous injection of
15mg/kg of type IV ConA (Sigma-Aldrich, St. Louis, MO). Following ConA injection mice
were anesthetized and sacrificed at various time points to collect blood, spleen and liver tissue.
Additional experiments were performed with a single previous IP injection of 100μg of mouse
hepcidin (PLP-3773, Peptides International, KY, USA) or sterile PBS two hours before the
ConA challenge.
Iron chelators
For some in vivo experiments, a 3 day-course of a hydroxypyridinone iron based chelator
(HPO CP28; 20 nmoles, i.p.) [16, 17] was performed before ConA challenge. In vitro, cells were
incubated with low doses of either HPO CP182 (5μM) or desferoxamine (DFO, 10μM, Sigma-
Aldrich). At these doses iron chelators had no discernible effects on lymphocyte cell death (S1
Fig).
Serum biochemistry and cytokine analyses
Serum was obtained after 10 minutes centrifugation at 8,000g and stored at -80C. The alanine
aminotransferase (ALT) plasma activities, which reflect the liver injury intensity, and the
serum iron level were quantified by automated measurements using the ADVIA 2400 System
kits (Siemens). Hematologic parameters were assessed by automated measurements using the
ADVIA 2120 System kits (Siemens). Serum cytokine levels were measured with multiplex fluo-
rescent bead-based Luminex technology according to manufacturer’s recommendation.
Liver histology
Formalin-fixed and paraffin embedded liver tissue sections were stained with haematoxylin
and eosin stained and the presence of hepatocyte necrosis, cellular infiltration and hepatocyte
cohesion were assessed by a senior liver histopathologist who was blinded to the identity of the
experimental groups (MB).
Isolation of non-parenchymal liver cells
After harvesting, the liver was perfused with sterile PBS through the portal vein, and digested
at 37°C in the presence of collagenase II 5%,(PAA Laboratories) and 100μg/mL DNase I
(Roche) for 30 minutes, as described [18]. The liver tissue was then passed through a 70μm
nylon mesh. Hepatocytes were then removed following low-speed centrifugation (60 xg, 2min-
utes) and liver mononuclear cells were isolated using Ficoll separation (800 xg, 20 minutes).
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Isolation of splenic and lymph node leukocytes
Spleens were passed through a 70um nylon mesh, and blood cells were removed using ammo-
nium chloride potassium lysing buffer (Life Technologies) for 5 minutes.
In vitro naïve CD4+ T cell stimulation
CD4+ naïve T cells were isolated from spleen and lymph nodes using EasySep Mouse Naïve
CD4+ T Cell Isolation Kit (Stem Cell). Enriched cells were labelled with 2.5 μMCFSE (Biole-
gend) during 10 minutes. A total of 250.103 cells were incubated during 5 days in 96 well-plate
coated with anti-CD3 anti-CD28 antibodies (2ug each, clone 145-2C11 and 37.51, respectively)
in RPMI-1640 (Life technologies) supplemented with 5% Foetal Calf Serum (Sigma-Aldrich),
1% penicillin-streptomycin and 2 mM L-glutamine and 50μM β-mercaptoethanol (Life
technologies).
Flow cytometry
Up to 1.106 cells were labelled in staining solution (PBS, Foetal Calf Serum 2%, 2mM EDTA).
Antibodies used were: APC/Cy7 anti-CD3e, PE/Cy7 anti-CD4, APC anti-CD25, PE anti-
CD44, FITC anti-CD62L (all from Biolegend). Dead cells were stained either with 7-AAD (Bio-
legend) or Livedead cell viability assay (Life Technologies). Cells were fixed using fixation solu-
tion 20 minutes at room temperature (Biolegend). For regulatory T cells labelling, FOXP3
Perm/Fix solution was use with PE anti-FOXP3 antibody (Biolegend) according to manufac-
turer’s instructions. Intracellular IFNγ staining was performed using permeabilisation buffer
following manufacturer’s instructions and FITC anti-IFNγ antibody and APC anti-IL4 anti-
body (Biolegend). Data were acquired on a BD FACSCanto II flow cytometer (BD) and ana-
lyzed employing FlowJo software (Tree Star).
RNA extraction and gene expression experiments
Liver or spleen tissue samples were cryopreserved at -80C in RNAlater reagent (Ambion). For
RNA extraction, samples were first homogeneized using a RNAse-free pestle in Trizol reagent
(Invitrogen), and total RNA was extracted according to TRIzol manufacturer’s protocol. DNA
was removed from total RNA preparations using Turbo DNA-free DNAse treatment
(Ambion). Quality and quantity were assessed with the Agilent 2100 Bioanalyzer (Agilent
Technologies) and Nanodrop ND-1000, respectively. Total RNA was then reverse transcribed
into cDNA using the High-Capacity cDNA Reverse Transcription Kit (Applied Biosystems). A
pre-amplification of cDNA was performed using pooled TaqMan Assays (final concentration
of 0.2X each) and the TaqMan PreAmp Master Mix using 10 cycles of amplification. qPCR was
performed using the 48.48 Dynamic Array (Fluidigm Corporation, CA, USA) following manu-
facturer's protocol using a BioMark Instrument (Fluidigm Corporation). To quantify transcript
levels, target gene Ct values were normalized using Ct values of HPRT1 as a reference gene to
generate -ΔCt values. Real-time PCR gene expression experiments were performed at 12 hours
post injection. This time point was selected to coincide with the peak of transaminases and
after determining that it required more than 3 hours to detect significant gene expression dif-
ferences (in a pilot experiment, Illumina microarrays performed at 3 hours showed minimal
differential gene expression (data not shown)).
Statistical analyses
Statistical analyses were performed with GraphPrism software. Student T-test was used for
comparison between two groups and ANOVA analysis with Tukey’s post-hoc correction for
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pairwise comparisons was used to compare more than 2 groups. Fisher test was used for cate-
gorical variables. P-values<0.05 (two-tailed) were considered statistically significant in all
analyses.
Results
Induction of mild iron deficiency by dietary manipulation
As compared to mice fed with an iron replete diet (IrRepl), mice fed with an iron deficient
diet (IrDef) displayed decreased serum iron (mean 73.22 ±56.49 versus 156.38 ±36.99 μg/dL;
p<0.0001) and serum transferrin saturation (18.80 ±6.32 vs 56.20 ±4.53%; p = 0.0013) (Fig 1).
In addition, liver tissue analysis revealed reduced liver iron stores and hepcidin (Hamp) gene
expression (p = 0.017 and p<0.0001, respectively) (Fig 1). None of these iron parameters were
found different between IrRepl diet and regular diet. As previously reported [19, 20], IrDef
mice also developed mild anemia (hemoglogin 107.6 ±46.10 versus 147.9 ±6.50 g/L; p = 0.028),
and increased platelet count (1405 ±469.2 versus 769.4 ±174.4 x109/L; p = 0.0004) (Fig 1).
IrDef mice remained otherwise healthy and gained weight at the same rate as IrRepl mice.
Mild iron deficiency does not modify the steady state immune cell
repertoire and systemic cytokine levels
To assess the impact of mild iron deficiency induced by an iron deficient diet on immune
parameters, we first compared liver and spleen immune cell subsets in IrDef and IrRepl mice.
Fig 1. Iron and haematological parameters in mice fed with an iron-deficient diet.Mice were fed for 3 weeks with an iron deficient (IrDef) or iron replete
(IrRepl) diet. Bar plots display mean and SEM. Abbreviations: RBC (red blood cells), Hb (Hemoglobin), Plts (platelets), WBC (white blood cells).
doi:10.1371/journal.pone.0136106.g001
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The 2 groups of mice displayed similar frequencies of intra-hepatic NK1.1+CD3+ NKT, CD4+
and CD8+ T cells, FOXP3+ T cells, cells and resident CD45+CD11b+F4.80+ Kupffer cells (Fig
2A). Similarly, no differences between IrDef and IrRepl splenic T cell subsets were noted, sug-
gesting that in the steady state IrDef does not induce major immunological effects (Fig 2B). We
next explored the effects of the iron deficient diet on pro-inflammatory and immunoregulatory
genes by measuring the expression of interleukins Il2, Il4, Il6, Il10, Il15, tumor necrosis factor α
(Tnf), transforming growth factor β (Tgfb1), interferon γ (Ifng), Cd86, forkhead box P3
(Foxp3), and Cd274 in whole livers, spleens and mesenteric lymph nodes from IrDef and IrRepl
mice. No significant changes were observed except for small decreases of TNFα (fold change
(FC) = -0.36, p = 0.032) and IFNγ (FC = -0.72, p = 0.044) transcript levels in the liver and
spleen of IrDef mice, respectively (Table 1). Serum cytokine levels were also measured using
Luminex technology, and again no significant changes between IrDef and IrRepl mice were
observed (Table 2).
Mild iron deficiency significantly dampens inflammatory liver damage
following ConA injection
To determine the functional effect of mild iron deficiency on intra-hepatic lymphocyte
responses we employed the ConA-induced immune-mediated hepatitis model. Following
ConA injection, the rise of alanine aminotransferases (ALT) was significantly lower in IrDef
Fig 2. Influence of iron levels on the immunophenotype of intra-hepatic (A) and spleen (B) leukocytes.
Mice were fed for 3 weeks with an iron deficient (IrDef) or iron replete (IrRepl) diet. Bar plots show the
frequency (mean and SEM) of specific leukocyte subsets in the liver (A) and spleen (B), as assessed by flow
cytometry after excluding dead cells.
doi:10.1371/journal.pone.0136106.g002
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mice than in IrRepl mice (p = 0.0028 and 0.0035 at 6 and 12 hours after ConA administration,
respectively) (Fig 3A). This was associated with reduced serum levels of the pro-inflammatory
cytokines IFNγ, IL6 and TNFα, which reached statistical significance at 6 hours after ConA
injection (p = 0.0037, 0.0013 and 0.0021, respectively; Fig 3B). Similar changes were observed
in the intra-hepatic expression of Il4 and Tnfa, whose transcript levels significantly decreased
in IrDef mice 12 hours after ConA injection (p = 0.0053 and p = 0.021, respectively; Fig 3C).
These data were consistent with the results of the liver histopathology analysis, which revealed
decreased hepatocyte necrosis and inflammatory infiltration in IrDef as compared to IrRepl
mice (p = 0.0082 and 0.0020, respectively) (Fig 3D).
Reduced iron availability impairs lymphocyte proliferation and activation
ConA administration triggers an inflammatory cascade that requires activation of T and NKT
lymphocytes and eventually results in liver tissue damage [15, 21]. Following ConA activation,
lymphocytes produce IFNγ, which is directly involved in the pathogenesis of ConA-induced
hepatitis [21–23]. Furthermore, NKT cells down-regulate NK1.1 and CD3 surface markers,
Table 1. Gene expression in liver, spleen andmesenteric lymph nodes (mesLN) of immune-related molecules from IrDef and IrRepl mice. FC is
exhibited as Log2 of IrDef/IrRepl values. Genes with significant differential expression are highlighted in bold.
Liver Spleen mesLN
Symbol Name FC p.value FC p.value FC p.value
Il2 Interleukin 2 0.75 0.090 -0.49 0.20 -0.26 0.28
Il4 Interleukin 4 0.32 0.14 -0.038 0.90 0.24 0.50
Il6 Interleukin 6 -0.20 0.39 -0.094 0.70 -0.48 0.15
Il10 Interleukin 10 -0.15 0.48 -0.11 0.74 0.060 0.83
Il15 Interleukin 15 0.098 0.68 -0.38 0.18 0.36 0.13
Ifng Interferon gamma 0.31 0.26 -0.72 0.044 0.40 0.54
Tnf Tumor necrosis factor -0.36 0.032 -0.29 0.38 0.024 0.94
Tgfb1 Transforming growth factor, beta 1 0.17 0.14 -0.26 0.14 -0.12 0.53
Foxp3 Forkhead box P3 -0.046 0.88 -0.32 0.34 0.052 0.85
Cd86 CD86 antigen 0.003 0.97 -0.41 0.083 -0.24 0.26
Cd274 CD274 antigen 0.10 0.38 -0.40 0.10 0.020 0.95
doi:10.1371/journal.pone.0136106.t001
Table 2. Serum level of cytokines measured by Luminex technology from IrDef and IrRepl mice. FC is
exhibited as Log2 of IrDef/IrRepl values.
Symbol Name FC p.value
IFNy Interferon gamma 0.85 0.59
IL-1α Interleukin 1alpha -0.73 0.57
IL-2 Interleukin 2 -3.35 0.20
IL-4 Interleukin 4 0.90 0.48
IL-6 Interleukin 6 -0.48 0.68
IL-10 Interleukin 10 -1.11 0.26
IL-15 Interleukin 15 1.47 0.10
IL-17 Interleukin 17 -1.69 0.15
CXCL10 chemokine (C-X-C motif) ligand 10 (IP-10) 0.008 0.96
CXCL9 chemokine (C-X-C motif) ligand 9 (MIG) 0.41 0.61
TNF α Tumor necrosis factor alpha -0.27 0.51
doi:10.1371/journal.pone.0136106.t002
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and the expression of these markers is inversely correlated to the degree of NKT activation
[24]. To explore if the effects of iron deficiency are mediated by defective lymphocyte activa-
tion, we isolated spleen and intra-hepatic lymphocytes at different time points following ConA
administration and assessed their phenotypic and functional properties. In IrDef mice, ConA
induced significantly less accumulation of liver-infiltrating CD3+ lymphocytes than in IrRepl
mice (p = 0.048 at 6 hours; Fig 4A). This was associated with a less striking decrease in the
expression of NK1.1 among CD3 cells (a marker of NKT cell activation) both at 3 and 6h fol-
lowing ConA injection (p = 0.0056 and 0.029, respectively; Fig 4A). In addition, as compared
to IrRepl, 3h after ConA administration intra-hepatic NKT and T lymphocytes from IrDef dis-
played lower intra-cellular IFNγ levels (p = 0.034 and 0.081, respectively; Fig 4B). Interestingly,
in contrast to the significant differences observed in the liver compartment, the frequence of
IFNγ-producing lymphocytes in the spleen was similar in IrDef and IrRepl mice (Fig 4C).
To confirm the effects of iron deficiency on T cells, we incubated splenocytes in vitro with
ConA (0.1mg/mL) in the presence of low doses of a specific hydroxypyridinone iron chelator
[16, 17] (HPO CP182; 5μM) or desferoxamine (DFO; 10μM). Iron chelation resulted in
impaired CD3+CD4+ T cell proliferation (p<0.001). Furthermore, iron chelators also
Fig 3. Iron deficiency results in attenuated immune-mediated hepatitis following ConA administration. (A) Serum levels of alanine aminotransferase
(ALT; IU/mL) before, 6 hours and 12 hours after administration of ConA in mice fed for 3 weeks with an iron deficient (IrDef) or iron replete (IrRepl) diet. (B)
Cytokine levels in serum samples collected before, 6 hours and 12 hours after the administration of ConA. (C) Transcript levels of Il4, Il6 and TNFα in liver
tissue samples collected before and 12 hours after the administration of ConA. (D) Representative liver histology (200x) at 12 hours after the administration of
ConA (upper panel) and histologic evaluation of necrosis and infiltration (lower panel).
doi:10.1371/journal.pone.0136106.g003
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hampered the activation of isolated CD4+ naïve T cells, which, following stimulation with
plate-bound anti-CD3/CD28, showed decreased CD25 expression and cell proliferation
(Fig 5).
The effects of iron deficiency in intra-hepatic inflammatory responses
are independent from changes in the gut microbiota
Given the influence of the gut microbiota on the liver environment [25] and the well-recog-
nized effects of iron levels on bacterial growth and intestinal microbial composition [26], we
next investigated if the reduced immune-mediated hepatitis observed in IrDef mice could be
mediated by changes in the number of gut bacteria. IrDef and IrRepl mice received a 3-week
course of a 4-antibiotic cocktail known to eliminate>90% of the fecal microbial populations,
and ConA was injected at the end of the 3-week period. The results were similar to those
Fig 4. ConA-induced T and NKT lymphocyte activation is reduced in iron deficiency. (A) Intra-hepatic
frequency of CD3+ expressing NK1.1 and CD3+NK1.1- at baseline, 3 hours and 6 hours after ConA injection.
(B) Intra-hepatic frequency of IFNγ production by NKT cells and T cells, defined as CD3+NK1.1+ and
CD3+NK1.1-, respectively, (left panel) and representative staining of IFNγ production by NKT cells (right
panel) (C) Frequency of splenic CD3+ NK1.1- T cells and the percentage of these ones producing IFNγ.
doi:10.1371/journal.pone.0136106.g004
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observed in mice receiving no antibiotics, with ALT levels being significantly reduced in IrDef
as compared with IrRepl mice (Fig 6A).
Intra-hepatic inflammatory responses are influenced by iron but not by
baseline hepcidin level
Iron deficiency results in reduced hepcidin expression which in some models can exert direct
immune regulatory effects [19]. We sought to determine if the effects of the iron deficient diet
on immune-mediated hepatitis could be due to differences in hepcidin levels rather than to
changes in iron status. Mice fed with a standard diet were treated with a 3 day-course of the
HPO CP28 iron chelator [16, 17] capable of specifically chelating intra-cellular iron without
decreasing intra-hepatic hepcidin expression (p = 0.48) (Fig 6B). Similarly to what was
observed employing iron deficient diet, mice treated with the iron chelator displayed a signifi-
cantly reduced ConA-induced hepatitis (p = 0.041) (Fig 6C). In parallel, administration of
exogenous hepcidin to IrDef mice 2h prior to ConA injection did not restore the blunted
immune-mediated hepatitis induced by ConA (p = 0.84; Fig 6D). Altogether, these results sug-
gest that iron restriction inhibits lymphocyte activation and ConA-induced hepatitis indepen-
dently from its effects on hepcidin secretion.
Fig 5. Iron chelation impairs CD4+ T cell activation and proliferation in vitro. (A) Percentages of CD3+CD4+ cells from splenocytes undergoing in
at least one division are represented with representative fluorescent histogram in the lower part. Splenocytes were incubated 96 hours in presence of ConA
(0.1mg/mL) and in presence of low doses of iron chelator (HPO CP182, 5μM or DFO, 10μM). (B) Percentages of CD3+CD4+ cells from isolated naive CD4+
cells undergoing in at least one division and (C) CD25 MFI are represented are displayed with representative fluorescent histogram in the lower part. Isolated
CD4+ naïve T cells incubated 5 days in presence of anti-CD3/CD28 plate-bound antibody (2μg each).Unmeans unstimulated cells.
doi:10.1371/journal.pone.0136106.g005
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Discussion
In the current study we investigated the impact of small changes in systemic iron status on
intra-hepatic lymphocyte-mediated immune responses. Our experiments were prompted by
the results of a recently reported multi-centre clinical trial of immunosuppression discontinua-
tion following liver transplantation [11, 27], in which liver recipients who developed rejection
exhibited lower iron storage markers (e.g. serum ferritin and serum and intra-hepatic hepcidin)
than recipients who successfully discontinued immunosuppression (operationally tolerant
recipients). These differences were statistically significant and very reproducible, but small in
magnitude and not clinically apparent. Given that spontaneous liver allograft tolerance is
known to require activation of recipient alloreactive T cells prior to lymphocyte deletion [12,
13, 28], we hypothesized that the iron/hepcidin axis could play an unappreciated role in the
regulation of intra-hepatic lymphocyte activation and function.
To test this hypothesis we selected a well-established model of immune-mediated hepatitis
that is tightly controlled by the interplay between cytokines, lymphocytes and Kupffer cells,
and in which intra-hepatic T/NKT cell activation is necessary for inflammatory liver damage
to occur [15, 21, 23]. We replicated the mild iron homeostasis changes observed in the cohort
of liver transplant recipients by feeding mice with an iron-deficient diet for just 3 weeks or by
administering low-dose iron-specific chelators. Short-term reduction in iron intake did not
have a significant impact on the hepatic steady-state immune homeostasis. On the other hand,
the magnitude of liver damage upon ConA stimulation was significantly reduced in iron defi-
cient mice, as assessed by decreased serum ALT levels, hepatic necrosis and intra-hepatic cellu-
lar infiltration. This was associated with a decrease in systemic levels of pro-inflammatory
cytokines such as IL6, TNFα and IFNγ, and with reduced intra-hepatic transcript levels of IL4
and Tnfα, all of them known to regulate ConA immune-mediated hepatitis.
A beneficial effect of dietary iron restriction or DFO iron chelation on liver inflammation
was previously reported in experimental animal models of thioacetamide-induced toxic
Fig 6. The inhibitory effects of iron deficiency in ConA-induced hepatitis are independent from changes in gut microbiome and hepcidin levels. (A)
ALT serum levels (IU/mL) before, and 12 hours after the administration of ConA to mice fed for 3 weeks with an iron deficient (IrDef) or iron replete (IrRepl)
diet, in the presence or absence of a 4-antibiotic (Atb) cocktail. (B) Relative expression of Hamp in liver tissue samples frommice receiving a 3 day-course of
HPO CP28 (20 nmoles, daily) compared to control mice receiving PBS (p = 0.48). (C) ALT serum levels 12 hours after ConA challenge in mice treated with
HPO CP28 or with PBS (p = 0.041). (D) ALT serum levels 12 hours after ConA challenge in mice pre-treated two hours before with a single intraperitoneal
injection of 100μg of mouse hepcidin or sterile PBS (p = 0.84). Bar plots display mean and SEM.
doi:10.1371/journal.pone.0136106.g006
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hepatitis [5] and Fas-induced fulminant hepatitis [6]. The anti-inflammatory effects of iron
restriction were attributed to a reduction in oxidative stress, and a decreased Kupffer and
hepatic stellate cell activation. While oxidative stress and macrophage activation are certainly
involved in amplifying liver damage following ConA administration, our findings that iron
deficiency results in decreased intra-hepatic T/NKT lymphocyte infiltration and reduced lym-
phocyte activation and effector function indicates that iron deficiency can also influence the
outcome of immune-mediated hepatitis by directly inhibiting intra-hepatic lymphocyte func-
tion. These results were confirmed in in vitro experiments in which isolated T cells were stimu-
lated with either ConA or anti-CD3/anti-CD28. In these experiments, iron chelation resulted
in impaired T cell activation and proliferation.
Our observations indicating that changes in iron status can regulate inflammatory organ
damage by influencing lymphocyte activation and proliferation are consistent with results
obtained in experimental autoimmune encephalomyelitis, a CD4+-driven model in which iron
deficiency prevents the development of immunopathology [7]. The mechanisms responsible
for T lymphocyte inhibition still remain to be fully deciphered. Intracellular iron deprivation
can impair the function of various enzymes involved in cell-cycle control, such as the ribonu-
leotide reductase [29], involved in DNA synthesis during phase S of cell cycle, cyclin A, and
Cdc2 [30]. Iron restriction can also inhibit the hydrolysis of phosphatidyl inositol-4,5-bipho-
sphate and the activity of kinase C protein, both of which are key in the cascade of intracellular
signalling events elicited by T cell activation [10, 31]. In addition, at least in the central nervous
system, DFO inhibits CXCL10 release following Toll-like receptor 3 (TLR3) engagement [32],
which can result in decreased tissue infiltration by CXCR3+ T cells.
Given that in some experimental models hepcidin has been reported to be capable of
directly inhibiting systemic inflammatory responses independently from iron levels [19, 33],
we explored the relative contributions of low iron versus low hepcidin levels in the regulation
of ConA-induced immune hepatitis. As expected, iron deprivation resulted in decreased hepa-
tocyte hepcidin expression, which persisted even following the induction of immune-mediated
liver damage (data not shown). We investigated the role of low iron levels by administering an
iron-specific chelator that does not influence hepatocyte hepcidin expression. Iron chelation
replicated the results observed by feeding the animals with an iron deficient diet. We next
tested the effect of injecting exogenous hepcidin prior to ConA challenge, which did not
modify the inhibitory effects of iron deprivation. We concluded that low iron levels are the
major determinant of the reduced liver inflammatory damage observed in iron deficient mice
following ConA administration. Considering the effector role played by macrophages in
ConA-induced hepatitis, our results appear to be in contrast with observations indicating that
iron-deprived macrophages exhibit increased release of pro-inflammatory mediators following
activation with LPS [19, 33]. While these observations still need to be clarified, as they have not
been confirmed by other studies [34], they suggest that iron deficiency elicits complex immu-
nological effects that are dependent on the specific cell being targeted and on the organ
involved in the inflammatory response. Hence, we speculate that the need for effective T cell
activation in order for ConA to induce immune mediated liver damage injection, in contrast to
what happens when systemic inflammation is provoked by LPS administration, is what deter-
mines the different outcomes observed in the 2 models in situations of iron deficiency.
Dietary iron manipulations can modify gut microbiota composition, which may influence
liver metabolism and immunogenicity [25]. To exclude this possibility we employed an antibi-
otic cocktail capable of eliminating>90% of the fecal microbial populations [14]. Iron defi-
ciency was still associated with significantly reduced immune mediated liver damage even in
the presence of markedly reduced intestinal bacterial populations. It is noteworthy, however,
that as compared with control animals receiving no antibiotic treatment, mice treated with
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antibiotics exhibited lower transaminase levels following ConA. This was particularly striking
in IrDef mice, in which hepatitis was almost completely abrogated. These observations are in
agreement with a previous report in which gentamycin decreased ConA-induced liver injury
by impairing intestinal dendritic cells function and intra-hepatic NKT cells activation [35].
Thus, in the ConA model, iron deficiency and antibiotic treatment are likely to deliver additive
effects by powerfully inhibiting T/NKT cell activation.
While serum Il6 level was decreased after ConA injection in IrDef, we observed an increase of
Il6 expression in the liver. Il6 is commonly described as a pro-inflammatory molecules but our
clear read-out of transaminases in the ConAmodel excludes an exacerbation of liver inflamma-
tion. Conversely, Il6 and the subsequent STAT3 phosphorylation have been described to be asso-
ciated with a reduction of liver injury [36, 37]. The increase Il6 expression is consistent with a
hepatoprotective effect in our setting, but whether IrDef directly participate to this increase of Il6
expression or this expression is hampered by higher liver damages in IrRepl remains to be deter-
mined. The inverse correlation of Il6 levels between serum and liver may reflect the different
immunological effects exerted by iron deficiency in the liver as compared with other compart-
ments, or may be the result of an opposite effect exerted on different cell types (e.g. hepatocytes
versus macrophages). Indeed, low hepcidin levels induced by IrDef could be responsible of
increased IL6 production by intra-hepatic macrophages as previously described [33].
In conclusion, we report here that iron deprivation impairs intra-hepatic lymphocyte activa-
tion and proliferation and results in a beneficial effect on immune mediated hepatitis. Given
the central role of the liver in the regulation of iron homeostasis, both as an iron reservoir and
as the main source of circulating hepcidin, these findings have implications for a variety of
inflammatory liver disorders. Further studies will be needed to ascertain whether all lympho-
cyte subsets are equally sensitive to iron deprivation, and to determine how iron influences
lymphocyte function in situations of chronic antigenic stimulation.
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